Search terms
Results 1 - 10 of 12 - ordered by :
Pages: 1 2

EuroIntervention Sirolimus-coated balloon for in-stent restenosis and de novo coronary artery disease: results from the multicentre NANOLUTE registry Kumar P., Dani S., Parikh K. AIMS Our objective ...

Date : 06/05/2016 Item size : 31733 bytes

EuroIntervention Clinical efficacy and safety of drug-coated balloon angioplasty as primary therapy / adjunctive therapy in primary PCI (nine-month clinical follow-up) Ho H., Loh K., Tan J., Ooi Y., ...

Date : 06/05/2016 Item size : 32703 bytes

EuroIntervention Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial Abbott Vascular, Santa ...

Date : 30/09/2010 Item size : 34999 bytes

EuroIntervention Five-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II ...

Date : 18/01/2013 Item size : 33906 bytes

EuroIntervention Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial The ABSORB Cohort A ...

Date : 20/01/2012 Item size : 33693 bytes

Cardialysis B.V., Clinical Research Organisation & Core Laboratories, Rotterdam, The Netherlands Background: SIMPLE II was a multi-centre, prospective registry study aimed at investigating the safety ...

Date : 20/11/2006 Item size : 37618 bytes

EuroIntervention New generation DES experience in the treatment of unprotected left main coronary artery disease: the next registry San Martino Hospital, Genova, Italy Aims: Few data are available ...

Date : 15/05/2012 Item size : 33634 bytes

EuroIntervention Angiographic comparison of biolimus-eluting vs. sirolimus-eluting coronary stents in patients with diabetes mellitus: the diabetes and DES V randomised angiography trial Odense ...

Date : 21/05/2013 Item size : 32419 bytes

Micell Technologies, Durham, USA Aims: Thirty patients with coronary artery disease were enrolled in the DESSOLVE I FIH clinical trial and were revascularised with the MiStent sirolimus-eluting ...

Date : 21/05/2013 Item size : 32763 bytes

EuroIntervention Spontaneous coronary artery dissection: characteristics of a large patient cohort and long-term clinical follow-up Carlos III Hospital - Cardiology Department, Madrid, Spain Aims: ...

Date : 17/05/2011 Item size : 36653 bytes